HGH Fragment 176-191
Human Growth Hormone Fragment 176-191
Overview
HGH Fragment 176-191 is the specific portion of the growth hormone molecule responsible for its fat-burning activity. This small peptide fragment represents amino acids 176-191 of the full 191-amino acid GH polypeptide. It promotes lipolysis (fat burning) and inhibits lipogenesis (fat storage) without the broader effects of full-length GH.
Mechanism of Action
Fragment 176-191 mimics the lipolytic action of growth hormone by stimulating fat cell breakdown and inhibiting new fat formation. It targets adipose tissue beta-3 adrenergic receptors and enhances fat oxidation. Unlike full-length GH, it does not compete for the GH receptor, does not cause hyperglycemia, and does not promote cell proliferation or affect IGF-1 levels.
Dosage Information
Typical Dose
250-500 mcg
Frequency
2 times daily
Administration
Subcutaneous injection
Notes
Administer on empty stomach — morning and pre-bed. Avoid carbohydrate intake for 30 minutes before and after injection. Fat-burning effect is enhanced with exercise. Cycle 8-12 weeks.
Potential Side Effects
Research References
Community Experiences
No experiences shared yet. Be the first!
Stacking Compatibility
In These Stacks
Quick Facts
- Administration
- Subcutaneous injection
- Typical Dose
- 250-500 mcg
- Frequency
- 2 times daily
- References
- 2 studies